Compare PDI & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDI | CRL |
|---|---|---|
| Founded | 2012 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 8.0B |
| IPO Year | N/A | 2000 |
| Metric | PDI | CRL |
|---|---|---|
| Price | $18.08 | $184.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $190.15 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 13.81% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,023,704,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.45 | $91.86 |
| 52 Week High | $19.60 | $202.72 |
| Indicator | PDI | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 46.70 | 62.90 |
| Support Level | $17.32 | $172.95 |
| Resistance Level | $18.12 | $180.95 |
| Average True Range (ATR) | 0.17 | 5.70 |
| MACD | 0.08 | 1.54 |
| Stochastic Oscillator | 73.08 | 95.04 |
PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investment portfolio includes mortgage-backed securities, investment-grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.